Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report

BACKGROUND: Clozapine is among the most effective antipsychotics used for treatment resistant schizophrenia. Adverse reactions to clozapine include neutropenia. In March 2020, at the start of the Coronavirus −19 pandemic, clinicians raised concerns regarding continuation of antipsychotic treatment,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Brain Behav Immun Health
Autors principals: Bonaccorso, Stefania, Ricciardi, Angelo, Ouabbou, Sophie, Theleritis, Christos, Ross-Michaelides, Arabella, Metastasio, Antonio, Stewart, Neil, Mohammed, Marwa, Schifano, Fabrizio
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2021
Matèries:
Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7840406/
https://ncbi.nlm.nih.gov/pubmed/33527097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbih.2021.100212
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars